|
Re: enzyme responsible for spread of breast cancer (LOXL2) new target for drugs
first they have to make a drug to inhibit LOX2, then they have to test it to find the right dosage and discover its side effects ie perhaps normal cells use LOX2 for something else so blocking it might be a problem, then they have to test it on enough patients to determine if it is better than the current standard of care and try to find out which subgroup of patients it benefits most (and balance this vs possible side effects)
Then they need to get government approval.
IF HOWEVER they can find a drug already approved for something else which does the same thing, it could start being given MUCH SOONER.
Cross your fingers!
|